Strengths
MAPS has a long-standing history since 1986, establishing itself as a credible authority in psychedelic research and advocacy.
The organization has a robust network of supporters, enhancing its outreach and community engagement.
MAPS is recognized for its evidence-based approach, which builds trust among mental health professionals and the general public.
The organization has successfully incubated groundbreaking research, such as the advancement of MDMA therapy for PTSD, which is nearing U.S. approval.
MAPS offers a comprehensive range of educational resources tailored for mental health professionals, enhancing their knowledge and practice.
The nonprofit's focus on harm reduction and mental health equity aligns with current societal values, making it a relevant player in the industry.
MAPS has demonstrated financial growth through strategic investments, such as the $6M backing of Numinus, indicating strong operational capabilities.
The organization actively advocates for drug policy reform, positioning itself as a leader in the movement for legal and responsible psychedelic use.